We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ESALF market cap is 11.89B. The company's latest EPS is JPY 186.9123 and P/E is 0.21.
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 642.83B | 697.09B | 647.39B | 770.87B | 752.72B |
| Operating Income | 85.23B | 122.8B | 53.22B | 53.75B | 40.04B |
| Net Income | 63.39B | 121.77B | 42.12B | 47.95B | 55.43B |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 1.07T | 1.06T | 1.09T | 1.24T | 1.26T |
| Total Liabilities | 419.54B | 359.51B | 362.07B | 467.78B | 440.78B |
| Total Equity | 651.98B | 702.63B | 727.94B | 771.53B | 822.57B |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 103.71B | 102.78B | 73.85B | 117.59B | -1.77B |
| Investing | -7.92B | -27.63B | -36.87B | -28.85B | -22.72B |
| Financing | -79.18B | -103.53B | -55.91B | -48.97B | -24.52B |
| Market Cap | 11.89B |
| Price to Earnings Ratio | 0.21 |
| Price to Sales Ratio | 0.02 |
| Price to Cash Ratio | 0.05 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 296.57M |
| Average Volume (1 week) | 1.13k |
| Average Volume (1 Month) | 850 |
| 52 Week Change | -30.05% |
| 52 Week High | 81.03 |
| 52 Week Low | 37.53 |
| Spread (Intraday) | 3.49 (8.25%) |
| Company Name | Eisai Co Ltd (PK) |
| Address |
4-6-10 koishikawa bunkyo, tokyo 112-8088 |
| Website | https://www.eisai.co.jp |
| Industry | pharmaceutical other prescript (H28) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
